We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Longevity Predicted by High Naive White Cell Counts

By Labmedica staff writers
Posted on 09 Jul 2008
Print article
Naive white blood cell counts have been proposed as a means to predict longevity and even lead to a way for everyone to live longer.

B-cells are vital components of the immune system, producing antibodies to combat foreign invaders, such as bacteria. Unlike mature B-cells, which are primed to attack foes the body has seen before, naive B-cells are ready and waiting to attack microbes not previously encountered. Therefore, the more naive B-cells present the longer someone is likely to be able to keep fighting off new infections, which might prolong life.

Sonya Vasto Ph.D. and her colleagues at the University of Palermo (Italy) took samples of white blood cells from 45 men and women aged between 75 and 90, who all had parents born between 1900 and 1908. They compared the numbers of naïve blood calls from those who had one parent who had reached 100 with those whose parents had died before reaching the average life expectancy for Italians (67 for men and 72 for women).

The two groups differed in the number of naive B-cells, a type of white blood cell that their blood contained. Our main finding was the increase in naive B-cells in individuals who had centenarian parents, said Dr. Vasto, who presented the results at a conference on aging organized by the Methuselah Foundation (Lorton, VA, USA). The conference took place in Los Angeles (CA, USA) from June 27-29, 2008.

Dr. Vasco said, "If people discover they have fewer naive B-cells, they might take extra steps to forestall infections.”


Related Links:
University of Palermo
Methuselah Foundation
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Aspergillus Test
REALQUALITY Aspergillus
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.